HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mamoru Harada Selected Research

Interferons

1/2020Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells.
9/2014Transfection of poly(I:C) can induce reactive oxygen species-triggered apoptosis and interferon-β-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system.
5/2010Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma.
11/2009Delayed growth of EL4 lymphoma in SR-A-deficient mice is due to upregulation of nitric oxide and interferon-gamma production by tumor-associated macrophages.
7/2003Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24+ prostate cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mamoru Harada Research Topics

Disease

81Neoplasms (Cancer)
02/2024 - 02/2002
24Prostatic Neoplasms (Prostate Cancer)
06/2016 - 07/2003
12Renal Cell Carcinoma (Grawitz Tumor)
02/2022 - 02/2005
9Carcinoma (Carcinomatosis)
12/2022 - 02/2006
8Colonic Neoplasms (Colon Cancer)
11/2023 - 05/2005
8Melanoma (Melanoma, Malignant)
01/2013 - 06/2002
7Pancreatic Neoplasms (Pancreatic Cancer)
04/2024 - 04/2013
5Breast Neoplasms (Breast Cancer)
12/2021 - 11/2005
4Body Weight (Weight, Body)
07/2022 - 10/2017
4Neoplasm Metastasis (Metastasis)
05/2006 - 09/2004
3Hypoxia (Hypoxemia)
02/2024 - 03/2017
3Lung Neoplasms (Lung Cancer)
12/2022 - 02/2004
3Infections
07/2022 - 01/2006
3Inflammation (Inflammations)
01/2016 - 09/2010
3Kidney Neoplasms (Kidney Cancer)
06/2015 - 10/2005
3Hematologic Neoplasms (Hematological Malignancy)
01/2009 - 07/2004
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2009 - 02/2007
3Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2005 - 01/2004
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2020 - 03/2018
2Carcinogenesis
05/2014 - 04/2002
2Experimental Melanoma
11/2012 - 06/2002
2Lymphoma (Lymphomas)
01/2012 - 11/2009
2Glioma (Gliomas)
05/2008 - 03/2007
2Stomach Neoplasms (Stomach Cancer)
07/2007 - 11/2005
2Adenocarcinoma
09/2006 - 11/2005
2Hypercalcemia (Milk Alkali Syndrome)
10/2005 - 02/2005
1Acidosis
02/2024

Drug/Important Bio-Agent (IBA)

49Peptides (Polypeptides)IBA
07/2020 - 02/2002
20AntigensIBA
01/2013 - 07/2003
14HLA Antigens (Human Leukocyte Antigens)IBA
11/2023 - 04/2005
14Immunoglobulin G (IgG)IBA
06/2008 - 07/2003
13Proteins (Proteins, Gene)FDA Link
09/2019 - 04/2002
10Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023 - 02/2007
10Messenger RNA (mRNA)IBA
02/2013 - 10/2005
10EpitopesIBA
05/2008 - 02/2002
9HLA-A24 AntigenIBA
05/2014 - 07/2003
8HLA-A2 Antigen (HLA A2 Antigen)IBA
05/2015 - 07/2003
6VaccinesIBA
11/2012 - 07/2003
5InterferonsIBA
01/2020 - 07/2003
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 05/2010
5Hormones (Hormone)IBA
06/2016 - 06/2004
5Protein Subunit VaccinesIBA
11/2012 - 10/2005
4Immune Checkpoint InhibitorsIBA
02/2024 - 06/2020
4Fluorouracil (Carac)FDA LinkGeneric
11/2023 - 07/2007
4AntibodiesIBA
02/2022 - 07/2003
4CytokinesIBA
09/2019 - 09/2009
4TNF-Related Apoptosis-Inducing LigandIBA
01/2018 - 01/2015
4CaspasesIBA
06/2016 - 09/2009
4Cancer VaccinesIBA
05/2015 - 12/2006
4HLA-A3 Antigen (HLA A3 Antigen)IBA
05/2015 - 10/2005
4Polycomb-Group ProteinsIBA
05/2015 - 09/2004
4Prostate-Specific Antigen (Semenogelase)IBA
02/2006 - 08/2003
3InterleukinsIBA
04/2024 - 09/2009
3navitoclaxIBA
04/2024 - 12/2021
3Arginine (L-Arginine)FDA Link
11/2023 - 07/2020
3Indicators and Reagents (Reagents)IBA
11/2023 - 08/2003
3Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2023 - 10/2020
3Doxorubicin (Adriamycin)FDA LinkGeneric
09/2019 - 05/2010
3Death Domain ReceptorsIBA
01/2018 - 04/2013
3LigandsIBA
09/2015 - 05/2012
3Neoplasm Antigens (Tumor Antigens)IBA
01/2015 - 06/2002
3Poly I-CIBA
09/2014 - 05/2012
3Interferon-gamma (Interferon, gamma)IBA
11/2009 - 07/2005
2GemcitabineFDA Link
04/2024 - 02/2013
2EnzymesIBA
02/2024 - 02/2004
2Small Interfering RNA (siRNA)IBA
02/2024 - 06/2017
2Antineoplastic Agents (Antineoplastics)IBA
02/2024 - 06/2016
2Apoptosis Regulatory ProteinsIBA
07/2022 - 01/2018
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2022 - 05/2006
2ABT-737IBA
12/2021 - 11/2014
2abemaciclibIBA
12/2021 - 09/2019
2Pemetrexed (MTA)FDA Link
06/2020 - 03/2018
2Interleukin-6 (Interleukin 6)IBA
10/2017 - 01/2016
2Docetaxel (Taxotere)FDA Link
06/2016 - 11/2014
2Sorafenib (BAY 43-9006)FDA Link
06/2015 - 05/2014
2Caspase 9IBA
01/2015 - 11/2014
2ErythropoietinFDA Link
05/2014 - 05/2008
2pifithrinIBA
04/2013 - 01/2013
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2013 - 02/2005
2Interleukin-17 (Interleukin 17)IBA
01/2012 - 09/2009
2Enhancer of Zeste Homolog 2 ProteinIBA
11/2007 - 09/2004
2Androgen Receptors (Androgen Receptor)IBA
08/2007 - 11/2006
2HLA-A31 antigenIBA
04/2007 - 10/2005
2HLA-A*33 antigenIBA
04/2007 - 10/2005
2HLA-A11 AntigenIBA
04/2007 - 10/2005
2KinesinsIBA
03/2007 - 06/2005
2Complementary DNA (cDNA)IBA
03/2007 - 02/2002
2EstramustineFDA Link
01/2007 - 04/2005
2prostatic acid phosphataseIBA
11/2005 - 09/2004
2Parathyroid Hormone-Related ProteinIBA
10/2005 - 02/2005
1GalactosidasesIBA
04/2024
1Carbonic Anhydrase IXIBA
02/2024

Therapy/Procedure

40Immunotherapy
11/2023 - 06/2002
38Therapeutics
02/2024 - 04/2004
8Drug Therapy (Chemotherapy)
11/2023 - 07/2007
3Injections
10/2020 - 02/2013
3Cell- and Tissue-Based Therapy (Cell Therapy)
01/2009 - 02/2007
3Stem Cell Transplantation
01/2009 - 02/2007
2Oral Administration
01/2016 - 07/2007
2Prostatectomy (Retropubic Prostatectomy)
08/2007 - 06/2007